Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency

Executive Summary

At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.

You may also be interested in...



Biden Budget Proposal Includes $905M For Medical Supply Stockpile

The $1.5tn proposal includes limited information about the US FDA, but makes pandemic recovery a clear priority.

ACA Champion Becerra Confirmed As HHS Chief

The former Congressman and California attorney general was confirmed with only one GOP vote. He’ll be integral to managing the pandemic as well as implementing the ACA and reimbursement policy.

Expanding Medicare Coverage For Digital Health Technologies Gains Support

AdvaMed outlined recommendations to expand Medicare coverage for digital health tech. Several lawmakers are also pushing to retain flexibilities after the COVID-19 public health emergency expires.

Related Content

Topics

UsernamePublicRestriction

Register

MT143554

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel